Orion Pharma at ISICEM 2013


Satellite Symposium: Therapeutic Strategies to Facilitate Cardiac Postoperative Care in the ICU


  • Location: Copper Hall
  • Chairpersons: Jean Mantz (Paris, France) & Robert Sladen (New York, USA)
  • Time: March 20, 2013 at 18:15


Programme (18:15-19:45)

  • Introduction
    • Dan Longrois (Paris, France)
  • Postoperative Cardiac Function: The role of levosimendan
    • Sonja Fruhwald (Graz, Austria)
  • Postoperative Cardiac Comfort: Dexmedetomidine as a platform for success
    • Robert Sladen (New York, USA)
  • Discussion & Questions

About Orion Pharma

Orion is a globally operating Finnish pharmaceuticals company. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Orion Pharma’s critical care product portfolio includes two own proprietary molecules, the alpha2-agonist dexmedetomidine (Dexdor®) for sedation of patients in intensive care units and the cardioprotective inodilator levosimendan (Simdax®) for treatment of acute heart failure.  

To find out more please visit Orion Pharma at ISICEM 2013, stand nr. 2.33 - 2.38 or visit: http://www.orion.fi/en/

Additionally you can find specialised information about Dexdor® and Simdax® at: www.dexdor.eu and www.simdax.com


Published on : Thu, 14 Mar 2013


Print as PDF

ISICEM2013, OrionPharma, dexdor, simdax Satellite Symposium: Therapeutic Strategies to Facilitate Cardiac Postoperative Care in the ICULocation: Copper HallChairpersons: Jean Mantz (Paris, France

No comment


Please login to leave a comment...

Highlighted Products